BMEA - Wall Street Estimates - Biomea Fusion, Inc.

Healthcare - Biotechnology - NASDAQ - US

$ 4.22

-0.706 %

$ 153 M

Market Cap

-1.05

P/E

Price Target Average

309.61%

Revenue Forecast Estimate

-0.00%

EBIT Estimate

25.99%

Net Income Estimate

14.69%

WALL STREET ESTIMATES

Wall Street Analysts Price Targets Biomea Fusion, Inc.

Wall Street analysts predict an average 1-year price target for BMEA of $17.3 , with forecasts ranging from a low of $5 to a high of $40 .

BMEA Lowest Price Target Wall Street Target

5 USD 18.48%

BMEA Average Price Target Wall Street Target

17.3 USD 309.61%

BMEA Highest Price Target Wall Street Target

40 USD 847.87%

REVENUE FORECAST

EBIT FORECAST

NET INCOME FORECAST

Free